PREVALENCE, CLINICAL MANIFESTATIONS, AND ASSOCIATED FACTORS OF LONG COVID-19
- Daniel Rojas-Bolivar(corresponding author),
- Fabiola Huaroto-Ramírez,
- ,
- Diana Gonzales Zurita,
- Ericson Gutiérrez
- Instituto Nacional de Salud, Lima,
- ,
- Museo de Historia Natural, Universidad Ricardo Palma
Open access
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 556-567 (12 pages)Journal (Volume, Issue Number)
Revista de la Facultad de Medicina Humana (Volume 22, Issue 3)Publication milestones
- Published - 01/07/2022
Publication status
ISSN
1814-5469Publication IDs
- Scopus: 85168286947
Abstract
Objective: The objective was to describe the prevalence, clinical manifestations, and associated factors of long COVID-19. Methods: A bibliographic search of systematic reviews and meta-analyses on long COVID-19 was carried out in MEDLINE (via PubMed) up to April 7th, 2022. 37 articles were found and 3 were included. Results: The quality of the evidence was evaluated through AMSTAR 2 criteria. The reported prevalence of long COVID- 19 was 43% (95% CI: 39% - 46%). The main clinical manifestations were weakness (41% [95% CI: 25% - 59%]), malaise (33% [95% CI: 15% - 57%]), fatigue (31% [95% CI: 24% - 39% %]), changes in concentration (26% [95% CI: 21% - 32%]) and shortness of breath (25% [95% CI: 18% - 34%]). Conclusion: Factors associated with long COVID-19 include female gender, the severity of initial symptoms, age, and the presence of comorbidities.